These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 32964962)

  • 1. LncRNA TMPO-AS1 promotes proliferation and migration in bladder cancer.
    He YC; Bi YG; Jiang L
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8740-8746. PubMed ID: 32964962
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Mitobe Y; Ikeda K; Suzuki T; Takagi K; Kawabata H; Horie-Inoue K; Inoue S
    Mol Cell Biol; 2019 Dec; 39(23):. PubMed ID: 31501276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TMPO-AS1/miR-98-5p/EBF1 feedback loop contributes to the progression of bladder cancer.
    Luo H; Yang L; Liu C; Wang X; Dong Q; Liu L; Wei Q
    Int J Biochem Cell Biol; 2020 May; 122():105702. PubMed ID: 32087328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA MAFG-AS1 Promotes the Progression of Bladder Cancer by Targeting the miR-143-3p/COX-2 Axis.
    Li D; Zhong S; Zhu Z; Jiang X; Zhang J; Gu J; Chen F
    Pathobiology; 2020; 87(6):345-355. PubMed ID: 33238264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA TMPO-AS1 promotes progression of non-small cell lung cancer through regulating its natural antisense transcript TMPO.
    Qin Z; Zheng X; Fang Y
    Biochem Biophys Res Commun; 2019 Aug; 516(2):486-493. PubMed ID: 31230752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA TMPO-AS1 promotes lung adenocarcinoma progression and is negatively regulated by miR-383-5p.
    Mu X; Wu H; Liu J; Hu X; Wu H; Chen L; Liu W; Luo S; Zhao Y
    Biomed Pharmacother; 2020 May; 125():109989. PubMed ID: 32062549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA TMPO-AS1 up-regulates the expression of HIF-1α and promotes the malignant phenotypes of retinoblastoma cells via sponging miR-199a-5p.
    Peng X; Yan J; Cheng F
    Pathol Res Pract; 2020 Apr; 216(4):152853. PubMed ID: 32139259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA AFAP1-AS1 promotes proliferation ability and invasiveness of bladder cancer cells.
    Gui JQ; Zhang C; Yang HB; Yu YW; Cui MR; Wang WS
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8747-8755. PubMed ID: 32964963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA TMPO-AS1 Aggravates the Development of Hepatocellular Carcinoma via miR-429/GOT1 Axis.
    Liu X; Shen Z
    Am J Med Sci; 2020 Dec; 360(6):711-720. PubMed ID: 32988599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Emerging Role of Thymopoietin-Antisense RNA 1 as Long Noncoding RNA in the Pathogenesis of Human Cancers.
    Zheng Q; Jia J; Zhou Z; Chu Q; Lian W; Chen Z
    DNA Cell Biol; 2021 Jul; 40(7):848-857. PubMed ID: 34096793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of AR-regulated lncRNA TMPO-AS1 correlates with tumor progression and poor prognosis in prostate cancer.
    Huang W; Su X; Yan W; Kong Z; Wang D; Huang Y; Zhai Q; Zhang X; Wu H; Li Y; Li T; Wan X
    Prostate; 2018 Dec; 78(16):1248-1261. PubMed ID: 30105831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA TMPO-AS1 accelerates glycolysis by regulating the miR-1270/PKM2 axis in colorectal cancer.
    Jin Y; Jiang A; Sun L; Lu Y
    BMC Cancer; 2024 Feb; 24(1):238. PubMed ID: 38383342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. lncRNA TMPO antisense RNA 1 promotes the malignancy of cholangiocarcinoma cells by regulating let-7g-5p/ high-mobility group A1 axis.
    Chang H; Yao Y
    Bioengineered; 2022 Feb; 13(2):2889-2901. PubMed ID: 35040749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA ZEB1-AS1 regulates miR-200b/FSCN1 signaling and enhances migration and invasion induced by TGF-β1 in bladder cancer cells.
    Gao R; Zhang N; Yang J; Zhu Y; Zhang Z; Wang J; Xu X; Li Z; Liu X; Li Z; Li J; Kong C; Bi J
    J Exp Clin Cancer Res; 2019 Mar; 38(1):111. PubMed ID: 30823924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of long noncoding RNA FGFR3- AS1 induces cell proliferation inhibition, apoptosis and motility reduction in bladder cancer.
    Liao X; Chen J; Liu Y; He A; Wu J; Cheng J; Zhang X; Lv Z; Wang F; Mei H
    Cancer Biomark; 2018 Feb; 21(2):277-285. PubMed ID: 29226855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression and Clinicopathological Correlation of Long Noncoding RNA TMPO-AS1 in Colorectal Cancer Patients.
    Mohammadrezakhani H; Baradaran B; Shanehbandi D; Asadi M; Hashemzadeh S; Hajiasgharzadeh K; Safaralizadeh R
    J Gastrointest Cancer; 2020 Sep; 51(3):952-956. PubMed ID: 31768869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TMPO-AS1 promotes cervical cancer progression by upregulating RAB14 via sponging miR-577.
    Yang J; Liang B; Hou S
    J Gene Med; 2019 Nov; 21(11):e3125. PubMed ID: 31483914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA TMPO-AS1 facilitates the progression of colorectal cancer cells via sponging miR-98-5p to upregulate BCAT1 expression.
    Ye J; Yan Y; Xin L; Liu J; Tang T; Bao X
    J Gastroenterol Hepatol; 2022 Jan; 37(1):144-153. PubMed ID: 34370878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA TMPO-AS1 promotes esophageal squamous cell carcinoma progression by forming biomolecular condensates with FUS and p300 to regulate TMPO transcription.
    Luo XJ; He MM; Liu J; Zheng JB; Wu QN; Chen YX; Meng Q; Luo KJ; Chen DL; Xu RH; Zeng ZL; Liu ZX; Luo HY
    Exp Mol Med; 2022 Jun; 54(6):834-847. PubMed ID: 35760875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DDX11-AS1exacerbates bladder cancer progression by enhancing CDK6 expression via suppressing miR-499b-5p.
    Li Q; Wang S; Wu Z; Liu Y
    Biomed Pharmacother; 2020 Jul; 127():110164. PubMed ID: 32422563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.